Featured Post

First Targeted ALS Drug Shows It Can Change the Disease

December 30, 2025

Early, sustained treatment with tofersen significantly slowed disease progression, stabilized function, and extended survival in patients with SOD1-related ALS.
 Read More

Other top stories

Could Swearing Be Good For Us?

December 29, 2025

Americans’ Mental Health Ratings Hit a New Low

December 24, 2025

When a Simple Invite Becomes a Workplace Stress Test

December 22, 2025

The latest news on Depression (MDD)

Other stories

Weekly Mind Reader: Beyond the Clinic Walls

December 19, 2025

Antidepressants in Pregnancy Reassessed

December 18, 2025

ADHD Strengths Tied to Better Wellbeing

December 17, 2025

Why Some Alzheimer’s Patients Decline Faster Than Expected

December 16, 2025

Single-Gene Mutation Appears to Drive Early-Onset Schizophrenia

December 15, 2025

Can Teen Body Dissatisfaction Predict Mental Health Problems?

December 12, 2025

Consensus Report on XT Use in Practice

Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe